Harvard scientist Jon Tilly proposed a radical new idea about how eggs are produced that called for the existence of ovarian stem cells which could continually produce new eggs. Stem cells are accepted as essential to sperm production in males. In men, the sperm stem cells (called spermatogonia) produce daughter cells that either make the final end product (new sperm cells) or make more stem cells in a continuing cycle of renewal.
Although accepted as dogma in the male system, the dogma regarding the ovary denied the existence of a renewable stem cell that could continually produce new eggs. The existing dogma was that every baby girl is born with all the eggs she will ever have and her eggs continually die off with age and are lost monthly after puberty. The ovarian stem cells was believed to only produce a defined number of eggs for a short time during fetal development but then became dormant for the rest of the females lifespan.
The problem with this dogma was that Tillys accounting of eggs lost in his experimental systems always ended up with more eggs than expected. The only way he could reconcile this discrepancy was to allow for the existence of a small population of ovarian stem cells which were capable of reactivating and contributing some eggs to the total. Most of his science colleagues were sure that he was wrong. It took him four years to prove the existence of these reactivated stem cells in the ovary by showing that stem cells he recovered from an aging ovary could be induced to make eggs again.
Tilly used cells from aged mouse ovaries, exposing them to the cellular environment of younger mouse ovaries and reactivating or rejuvenating the old stem cells which then started to produce eggs again. If the same could be done in humans, old ovaries could be reawakened to produce eggs. This would be a huge advance in the treatment of infertility since ovarian aging is considered irreversible. The only current treatment option for old ovaries which no longer produce eggs is to do IVF using eggs from a younger donor.
Unfortunately, it will likely be years, if not decades, before these scientific findings in a mouse model are converted to clinical treatments for patients. The typical path for moving a scientific discovery from bench to bedside treatment is excruciatingly slow because the clinical treatment must be proven to be both effective and safe. For reproductive treatments which produce children, the safety and health of those children is the primary concern.
First, treatments must be shown to be safe for both mother and offspring in other animal models, especially other primates like rhesus monkeys and chimpanzees. In vitro experiments with rare donated human ovarian tissue would also be necessary. If all the animal research and in vitro human tissue work still looks promising, clinical trials might start in humans, if institutional review boards give approval for the proposed research in humans. Because in vitro fertilization research is not funded by NIH, and stem cell funding is subject to erratic funded by NIH or individual states, this research will be slower to yield new clinical treatments compared to other non-controversial areas like cancer research.
Although anyone reading this today is unlikely to benefit personally from this research, it still opens a small door to the possibility of new treatments for advanced maternal age that dont involve giving up the genetic link between mother and child.
You can read more about Tillys research in this BioTechniques article Where do babies come from?.
Another scientist, Karim Nayernia, professor of stem cell biology at Newcastle Universitys Institute of Human Genetics, is researching the use of spermatogonial stem cells to revive fertility in the male, after chemotherapy or disease. In mouse studies, he was able to use stem cells from bone marrow and coax it to become sperm stem cells called spermatogonia. Transplants of these new stem cells into mice whose testicles were depleted of stem cells allowed the mice to father offspring. In 2009, his research team reported that they successfully produced human sperm-like cells from embryonic stem cells in vitro. There remain questions about the health of the mice offspring so this research is a long way from clinical use, but offers the possibility of new treatments for male infertility.
Another researcher, Richard Behringer, professor of genetics at the University of Texas MD Anderson Cancer Center has been using stem cells to understand what makes us male or female. His research may one day allow same sex couples to have genetic children together. First, he took stem cells from male mice, cultured them in such a way to cause the X and Y chromosomes to separate in culture, creating some daughter cells that were XO, a genetic type that creates a female genotype due to lack of a Y chromosome. Genetic material from these XO cells was used to replace the genetic material inside a mouse blastocyst. A surrogate mother mouse carried the XO blastocyst and gave birth to a female pup. The ovary of the pup produced eggs that contained DNA from the feminized male stem cell. This female offspring mated naturally with male mice to produce offspring from (essentially) two males.
Dr. Behringer is also investigating techniques to introduce a second X chromosome into an XO cell, creating a female egg cell from a male stem cell. There are decades of basic biology research to be done here which will provide insights into how sex differentiation works. These preliminary experiments are decades away from clinical use and may never be implemented if society as a whole remains uncomfortable with using science to circumvent male-female procreation.
Reproductive research has always been controversial. IVF was considered amoral and possibly dangerous in the beginning and yet is widely accepted today. Public opinion tends to come around if a new medical intervention is effective and causes no harm. If nothing else, stem cell research is unlocking the most basic secrets nature has and although we cant predict what new fertility treatments, if any, might arise, it is certainly worth understanding reproduction at the cellular and molecular level. Stem cells are proving extremely useful for reproductive research.
2011, Carole. All rights reserved.
Posted on January 12, 2011 at 2:03 pmhttp://fertilitylabinsider.com/2011/01/rejuvenating-gonads-with-stem-cells/http://fertilitylabinsider.com/2011/01/rejuvenating-gonads-with-stem-cells/trackback/Categorised under : Ethical Issues , Fertility Preservation , Inside the Lab , Repro Bio 101Tagged with : eggs from stem cells , reproductive research , sperm from stem cells , stem cell research
Read more from the original source:
Rejuvenating gonads with stem cells - Fertility Lab Insider
- Cardiovascular Glossary A-Z (All) | Texas Heart Institute - January 4th, 2023
- ADC Therapeutics Announces Abstracts to be Presented at the Tenth Annual Meeting of the Society of Hematologic Oncology (SOHO 2022) - Business Wire - September 25th, 2022
- GVHD in the Context of Stem Cell or Allogeneic Transplant - Cancer Network - August 22nd, 2022
- De-extinction Company Aims to Resurrect the Tasmanian Tiger - Scientific American - August 22nd, 2022
- Dean Kamen on the power of celebrating your own obsoletion - TechCrunch - July 27th, 2022
- Westin and Sehn Carve Out the Role of CAR T-Cell Therapy and Transplant in Primary Refractory DLBCL - OncLive - July 27th, 2022
- Unanticipated findings cast new light on the genetic regulation of different brain tumors - Baylor College of Medicine - July 27th, 2022
- Chaotic response in Uvalde, Parkland shooter faces death penalty, mall shooting leaves 3 dead and jury selection begins in Bannon trial | Hot off the... - July 19th, 2022
- Stem Cells, Abortion, Baby Parts, & the Ukraine - Physicians for Life - June 22nd, 2022
- INVECTYS, MD ANDERSON AND CTMC ANNOUNCE STRATEGIC COLLABORATION FOR CAR T CELL THERAPY DEVELOPMENT - BioSpace - June 22nd, 2022
- Quizartinib Plus Chemotherapy Significantly Improved Overall Survival Compared to Chemotherapy in Patients with Newly Diagnosed FLT3-ITD Positive... - June 13th, 2022
- Texas Family Fights to Access $2.1 Million Treatment for Baby - NBC 5 Dallas-Fort Worth - May 15th, 2022
- La Conner native raising funds to cure blood cancer - La Conner Weekly News - May 2nd, 2022
- CORRECTING and REPLACING -- Affimed NV - GlobeNewswire - May 2nd, 2022
- StudyFinds Blotter: Other Notable Health Research From April 28, 2022 - Study Finds - May 2nd, 2022
- Sung to lead cancer institute; Bankston wins fellowship - ASBMB Today - April 19th, 2022
- Houston teen first in Texas to become own donor to reverse sickle cell anemia - FOX 26 Houston - March 25th, 2022
- Oleic Acid, a Key to Activating the Brains Fountain of Youth - Neuroscience News - March 25th, 2022
- Stem Cell Therapy Boosts Outcomes for Some Heart Failure Patients - HealthDay - November 22nd, 2021
- Quizartinib Added to Chemotherapy Demonstrates Superior Overall Survival Compared to Chemotherapy Alone in Adult Patients with Newly Diagnosed... - November 22nd, 2021
- BioBridge Global continues history of innovation with umbilical cord collection and processing under cGMP standards for further manufacture - Yahoo... - November 22nd, 2021
- Immatics to Present Update on Lead ACTengine Program IMA203 Targeting PRAME at the Society for Immunotherapy of Cancers 36th Annual Meeting - Yahoo... - November 8th, 2021
- Affimed Announces Poster Presentations at the 63rd American Society of Hematology Annual ... - Tyler Morning Telegraph - November 8th, 2021
- ADC Therapeutics Announces Abstracts to be Presented at the 63rd ASH Annual Meeting - StreetInsider.com - November 8th, 2021
- The Power of the Immune System: New Treatment for Painful Blood Cancer Side Effect - Curetoday.com - October 28th, 2021
- Durham firm offering up to $10,000 for researchers to use its intestinal technology - WRAL Tech Wire - October 16th, 2021
- Elevated cryptic transcription emerges as a common theme in aging mammalian cells - Baylor College of Medicine News - August 31st, 2021
- Insulin-producing implants are being developed to control Type 1 diabetes - Health Europa - August 5th, 2021
- Cryptic Transcription in Mammalian Stem Cells Linked to Aging - Technology Networks - August 5th, 2021
- Overview of DLBCL - Targeted Oncology - August 5th, 2021
- The True Crime Junkies and the Curious Case of a Missing Husband - VICE - August 5th, 2021
- FROM THE LABS: Hispanic Heritage Spotlight: Interview with Dr. Nino Rainusso - Baylor College of Medicine News - November 13th, 2020
- UPMC nurse practitioner hailed 'healthcare hero' on live TV - Altoona Mirror - October 31st, 2020
- BrainStrom Cell Therapeutics (NASDAQ:BCLI) Enters Agreement With Catalent (NYSE:CTLT) For Manufacture Of Its NurOwn Cell Therapy - BP Journal - October 31st, 2020
- Dr. Daisy Ayim, Cosmetic Surgeon, ObGyn, Business Owner and Entrepreneur, Is Revolutionizing The Integration Of Women's Health And Cosmetic Care -... - October 31st, 2020
- Five Indian American Researchers Named Among NIH 2020 New Innovator Awardees - India West - October 21st, 2020
- Reliable tumor detection by whole-genome methylation sequencing of cell-free DNA in cerebrospinal fluid of pediatric medulloblastoma - Science... - October 21st, 2020
- Biotechnology could change the cattle industry. Will it succeed? - Salon - September 8th, 2020
- STEM CELLS | VitaDrip IV Therapy | Texas - June 26th, 2020
- New Preclinical Data Demonstrates Immune-Enhancing Effects of Triple I/O Combination Therapy with BeyondSpring's Plinabulin - BioSpace - June 23rd, 2020
- Tau: Why Alzheimer's Worsens Fast in Some, Slowly in Others - Alzforum - June 23rd, 2020
- Scholarly Perspectives on COVID-19, Part 1: This Was Only a Matter of Time - Southern Newsroom - June 23rd, 2020
- Texas Stem Cell Law Opens Door for Controversial Treatments - June 11th, 2020
- Who's to blame? These three scientists are at the heart of the Surgisphere COVID-19 scandal - Science Magazine - June 9th, 2020
- FTC ramps up enforcement with new wave of warning letters - NutraIngredients-usa.com - June 9th, 2020
- UT Student Awarded Prestigious Astronaut Scholarship - UT News | The University of Texas at Austin - June 9th, 2020
- South Sound Community Bands Together To Save Local Lives - southsoundtalk.com - May 7th, 2020
- Pfizer, NYU working on innovative coronavirus vaccine that could be ready by end of summer - NBC News - May 7th, 2020
- How industry hopes to take on COVID-19 - Bioprocess Insider - BioProcess Insider - March 8th, 2020
- Meng Hsieh, Andrew Shubin - The New York Times - March 8th, 2020
- Jimbo Fisher's Kidz1stFund, Aggie Corps of Cadets team up for Be the Match bone marrow donor registry drive - Bryan-College Station Eagle - March 2nd, 2020
- Texas A&M Researcher Named To National List Of Inspiring Black Scientists - Texas A&M University - March 2nd, 2020
- What to do in Madison: March 2-8, 2020 - The Bozho - March 2nd, 2020
- Cumberland County family turns to non-FDA approved stem cell treatment to help two-year-old son with cerebral palsy - FOX43.com - February 27th, 2020
- Recombinetics Announces Collaboration with University of Texas Southwestern to Advance Regenerative Medicine Through Therapeutic Cell, Tissue, and... - February 27th, 2020
- Stem Cell Therapy for Joints & Spine in Austin Texas - January 28th, 2020
- El Paso scientists to deliver 3D bioprinted miniature hearts to the ISS - 3D Printing Industry - January 28th, 2020
- El Paso scientists team up for heart research project at the International Space Station - KVIA El Paso - January 28th, 2020
- Drugs, Biologics, and Regenerative Medicine in 2019: A Successful Year Ends with Promise of a More Challenging 2020 - JD Supra - December 18th, 2019
- Incoming Faculty Bring New Areas of Research to Rensselaer - Rensselaer Polytechnic Institute - September 24th, 2019
- Nivolumab as an addition to frontline therapy of AML in younger patients - AML Global Portal - September 24th, 2019
- Interview: BIOLIFE4D is The First US Company to Bioprint a Mini-Heart (for Cardiotoxicity Testing) - 3DPrint.com - September 24th, 2019
- Stem cells regrow leg's long bones - WNDU-TV - September 22nd, 2019
- A breakthrough in the battle against citrus greening - Gainesville Sun - September 22nd, 2019
- Comparing Mymetics (OTCMKTS:MYMX) & Crispr Therapeutics (OTCMKTS:CRSP) - TechNewsObserver - September 22nd, 2019
- STEM CELL THERAPY & TREATMENTS Texas Regional Health - September 10th, 2019
- Fast Facts: Stem Cells 101 Vital Record - September 10th, 2019
- Keller, TX Stem Cells | Neuropathy & Pain Centers of Texas - May 31st, 2019
- Arlington Stem Cells | Neuropathy & Pain Centers of Texas - May 1st, 2019
- Houston, Texas Stem Cell Transplants, Richmond, Sugar Land ... - April 21st, 2019
- Fort Worth Stem Cells | Neuropathy and Pain Centers of Texas - April 15th, 2019
- Stem Cell Rejuvenation Therapy | Totalhormonegenetherapy.com - April 15th, 2019
- Our Doctors - Knee Stem Cells - March 17th, 2019
- Stem Cell Treatment Center in Dallas, Texas | Stem Cell ... - March 17th, 2019
- Neuropathy & Pain Centers of Texas - Stem Cells & Neuropathy - February 6th, 2019
- Stem Cell Doctor Dallas Dr. Darcy Brunk | Dallas, Plano ... - January 25th, 2019
- Four Types of Stem Cells - Texas Right to Life - December 15th, 2018
- Texas | The Stem Cellar - December 5th, 2018
- Dallas, Texas, Stem Cells Treatment, Legal, Ft. Worth ... - November 16th, 2018
- HB810 | Right to Try Law | Texas Stem Cell Law | StemGenex - October 13th, 2018